Fitzpatrick, Molly K.. How updates to the NCCN guidelines expanding germline testing eligibility has influenced genetic counseling practices. Retrieved from https://doi.org/doi:10.7282/t3-72kw-c195
DescriptionAs our knowledge of genetics and availability of treatment options advances, it is becoming increasingly important to identify patients with a germline mutation that increases their risk for cancer in order to appropriately screen and treat them. Version 1.2019 of the National Comprehensive Cancer Network’s (NCCN) Genetic/Familial High Risk Assessment guidelines expanded germline testing eligibility to all patients with personal histories of metastatic prostate or pancreatic cancers. This study aimed to explore if cancer institutions are seeing an increase in the number of referrals they are receiving for these indications and determine what (if any) changes they have made to their genetic counseling model to accommodate for the increase in patients. Participants were issued an anonymous survey through the National Society of Genetic Counselor’s email listserv. We found that most cancer institutions are seeing an increase in referrals and have made several changes including hiring changes and utilizing alternative service delivery models. Our findings suggest that these guideline updates have influenced the cancer genetic counseling process at some institutions, and future updates may continue to shape the way genetic counseling is performed.